- Home
- ZYXI vs INCR Comparison
ZYXI vs INCR Comparison
Compare ZYXI & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZYXI
- INCR
- Stock Information
- Founded
- ZYXI 1996
- INCR 1994
- Country
- ZYXI United States
- INCR Israel
- Employees
- ZYXI N/A
- INCR N/A
- Industry
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- INCR Biotechnology: Pharmaceutical Preparations
- Sector
- ZYXI Health Care
- INCR Health Care
- Exchange
- ZYXI Nasdaq
- INCR Nasdaq
- Market Cap
- ZYXI 66.5M
- INCR 76.7M
- IPO Year
- ZYXI N/A
- INCR N/A
- Fundamental
- Price
- ZYXI $2.02
- INCR $1.59
- Analyst Decision
- ZYXI Buy
- INCR
- Analyst Count
- ZYXI 3
- INCR 0
- Target Price
- ZYXI $6.00
- INCR N/A
- AVG Volume (30 Days)
- ZYXI 176.4K
- INCR 8.3K
- Earning Date
- ZYXI 07-24-2025
- INCR 05-01-2025
- Dividend Yield
- ZYXI N/A
- INCR N/A
- EPS Growth
- ZYXI N/A
- INCR N/A
- EPS
- ZYXI N/A
- INCR N/A
- Revenue
- ZYXI $172,401,000.00
- INCR $65,575,323.00
- Revenue This Year
- ZYXI N/A
- INCR $69.54
- Revenue Next Year
- ZYXI $19.55
- INCR $41.75
- P/E Ratio
- ZYXI N/A
- INCR N/A
- Revenue Growth
- ZYXI N/A
- INCR N/A
- 52 Week Low
- ZYXI $1.66
- INCR $1.17
- 52 Week High
- ZYXI $10.62
- INCR $3.00
- Technical
- Relative Strength Index (RSI)
- ZYXI 40.53
- INCR 57.76
- Support Level
- ZYXI $2.21
- INCR $1.51
- Resistance Level
- ZYXI $2.66
- INCR $1.62
- Average True Range (ATR)
- ZYXI 0.20
- INCR 0.04
- MACD
- ZYXI 0.02
- INCR -0.00
- Stochastic Oscillator
- ZYXI 5.19
- INCR 74.79
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. The products are distributed to hospitals, pharmacies, research, and government organizations. The company has two segments namely: Cannabis segment and Biomed segment, out of which it derives maximum revenue from Cannabis segment.